Target intelligence / Profile preview

Hydrochloric acid in stomach lumen (HCl)

Target
HCl
Molecular classification
Other (inorganic acid; not a receptor, enzyme, transporter, etc.)
01

Overview

Hydrochloric acid in the stomach lumen is produced by parietal cells lining the stomach through the action of H^+/K^+ ATPase (the proton pump)[5][7][10]. This creates a highly acidic environment (pH 1–2), essential for digesting proteins, activating digestive enzymes (notably pepsin), and protecting against ingested pathogens[2][3][10]. Acid secretion is regulated by complex neural, hormonal, and paracrine signals, primarily acetylcholine, gastrin, and histamine stimulation of parietal cells[5][9]. Therapeutic control of gastric acid involves drugs that act primarily on the parietal cell or acid itself, but the acid as found in the lumen is not a drug target per se. Excess, reduced, or misregulated acid is implicated in a range of gastrointestinal diseases[5][10].

Other names
Gastric acidStomach acidGastric hydrochloric acid
02

Mechanism of action

Proton pump inhibitors inhibit the H^+/K^+ ATPase in parietal cells, blocking acid secretion[5][10] H2 receptor antagonists block histamine stimulation of parietal cells, reducing acid secretion[5][10] Antacids neutralize hydrochloric acid by simple acid-base reaction in the stomach lumen Potassium-competitive acid blockers inhibit the K^+-binding site of the H^+/K^+ ATPase

03

Biological functions

Protein digestion (activates pepsinogen to pepsin)Defense against pathogens (maintains strongly acidic environment that inhibits microbial growth)Food breakdown (denatures proteins for enzymatic action)Facilitates absorption of minerals and nutrients
04

Disease associations

Peptic ulcer disease (excess or uncontrolled acid damages mucosa)Gastritis (associated with abnormal acid secretion)Gastroesophageal reflux disease (acid injury to the esophagus)Acid deficiency (can lead to nutrient malabsorption)Other
05

Safety considerations

Excess suppression of acid can impair digestion and increase risk for gastrointestinal infections (e.g., Clostridioides difficile)Potential nutrient malabsorption, especially vitamin B12, iron, calciumLong-term suppression associated with bone fracture risk, hypergastrinemia
06

Interacting drugs

Proton pump inhibitors (e.g., omeprazole, esomeprazole)

4 more in the full profile.

07

Biomarkers

Gastric pH (for monitoring efficacy of acid suppression therapy)Serum gastrin (may be elevated in hypochlorhydria)

Beyond the preview

Go deeper on Hydrochloric acid in stomach lumen (HCl).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hydrochloric acid in stomach lumen (HCl).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call